Establishing secure connection…Loading editor…Preparing document…

Letter Appointment Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Investment Intent Letter and Appointment of the Representative Agreement

This Investment Intent Letter and Appointment of the Representative Agreement (this "Agreement") dated as of , is entered into by and among the persons whose names appear on the signature pages hereto as "Vendors" (collectively the "Vendors"), or the "Representative," who is also a "Vendor"), and , a Delaware corporation ("Purchaser"). Unless otherwise defined herein, all capitalised terms used herein shall have the meanings assigned to them in the Purchase Agreement (as defined below).

RECITALS

A. Vendors and Representative collectively own all of the issued and outstanding ordinary shares (the "Company Stock") of , a limited company organised under the laws of England (the "Company"), and are "Vendors" defined in the Purchase Agreement described below.

B. Pursuant to the terms and conditions of that certain Agreement for Sale and Purchase of Shares (the "Purchase Agreement") dated of even date herewith by and among Purchaser and Vendors, Purchaser is acquiring all the Company Stock.

C. In connection with the Purchase Agreement, the Vendors will be issued shares of common stock, US$0.0001 par value, of Purchaser (the "Purchaser's Shares") in exchange for their shares of Company Stock (and the Purchaser's Shares issued to the Vendors are herein referred to as the "Consideration Shares").

D. The Vendors desire to appoint as their "Representative" and attorney-in-fact pursuant to the terms and conditions hereof.

E. The Vendors desire to make certain representations and warranties to Purchaser to satisfy various U.S. securities law requirements.

AGREEMENT

NOW THEREFORE, in consideration of the respective covenants and promises contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

SECTION 1. APPOINTMENT OF REPRESENTATIVE. Each Vendor (other than Representative) hereby makes, constitutes and appoints as his true and lawful attorney-in-fact with full power and authority to take any and all action as is contemplated to be taken by such Vendor by the terms of the Purchase Agreement; including, without limitation, the following:

(a) to administer the defence and/or settlement of any claims for which the Vendors may be liable to Purchaser pursuant to the Purchase Agreement; such Vendor expressly acknowledges and agrees to such obligations set forth in the Purchase Agreement; and

(b) to make, execute and deliver all agreements, Schedules, exhibits and certificates required to be executed by the Vendors and delivered to Purchaser in accordance with the terms and conditions of the Purchase Agreement, including but not limited to the escrow agreement of even date herewith among the Vendors, Purchaser and the escrow agent named therein (the "Escrow Agreement"), and to act as proxy, if necessary, with respect to the escrow shares delivered pursuant to the Escrow Agreement.

SECTION 2. ACCEPTANCE OF APPOINTMENT. Representative hereby accepts his appointment as Representative and agrees to carry out in good faith the responsibilities undertaken hereby and in accordance with the terms and conditions of the Escrow Agreement and the Purchase Agreement.

SECTION 3. POWER OF ATTORNEY IRREVOCABLE, ETC. Each Vendor does hereby ratify and confirm all that Representative shall do or cause to be done by virtue of this Agreement. Each Vendor agrees that the power of attorney granted hereby to Representative is a special power of attorney coupled with an interest, is irrevocable, shall not terminate upon the death of such Vendor and shall be effective from the date hereof until or upon termination of this Agreement. Each Vendor hereby renounces all right to revoke the power of attorney granted herein and to appoint another person or entity to perform the acts of Representative, except for successors hereunder.

SECTION 4. SUCCESSOR REPRESENTATIVE. Each Vendor agrees that in the event ceases to act as Representative, then the Vendors by vote or assent of Vendors holding a majority of the Consideration Shares shall select a successor from among the remaining Vendors. If none of the remaining Vendors will accept such appointment, then may select a successor who shall be such person or entity reasonably acceptable to the remaining Vendors. Any successor to shall have all the rights, powers and obligations of Representative under this Agreement.

SECTION 5. COSTS. All charges, fees or other expenses or costs of any Representative, if any, shall be borne and paid by the Vendors on a pro rata basis in accordance with their respective Allocable Percentages as set forth on Schedule 1 to the Purchase Agreement.

SECTION 6. LIMITATION OF LIABILITY OF REPRESENTATIVE AND INDEMNITY. Each of the Vendors agrees that in performing any of his duties, Representative shall not incur any liability to anyone for damages, losses or expenses for any reason except for wilful negligence or intentional misconduct. Without limiting the foregoing, each Vendor specifically agrees that Representative shall be entitled to act upon advice of his counsel given with respect to any questions relating to his duties and responsibilities as Representative hereunder without incurring any liability to the Vendors or to any other person. The Vendors agree to indemnify and hold harmless Representative against and in respect of any and all losses, claims, damages, liabilities and expenses (including, without limitation, reasonable costs of investigation, counsel and accountants' fees and disbursements) which may be imposed upon or incurred by Representative in connection with the performance of his duties hereunder on a pro rata basis in accordance with their respective Allocable Percentages as set forth on Schedule 1 to the Purchase Agreement.

SECTION 7. LIMITATION OF LIABILITY OF PURCHASER AND INDEMNITY. Each of the Vendors agrees that Purchaser shall be entitled to rely exclusively on the instructions and decisions of the Representative as to the matters for which the Representative has authority to act on behalf of the Vendors pursuant to this Agreement, and no Vendor shall have any cause of action against Purchaser in reliance upon the instructions or decisions of the Representative in accordance with the terms and conditions set forth herein. The Vendors agree to indemnify and hold harmless Purchaser against and in respect of any and all losses, claims, damages, liabilities and expenses, including reasonable costs of investigation, counsel fees and disbursements, which may be imposed upon or incurred by Purchaser in connection with its reliance upon the instructions and decisions of the Representative in accordance with the terms and conditions set forth in this Agreement, on a pro rata basis in accordance with their respective Allocable Percentages as set forth on Schedule 1 to the Purchase Agreement.

SECTION 8. SHAREHOLDER REPRESENTATIONS AND WARRANTIES. As a condition to the receipt of the Consideration Shares, of the Vendors represents and warrants to, and covenants with, Purchaser as follows:

(a) Such Vendor is aware of Purchaser's business affairs and has acquired sufficient information about Purchaser to reach an informed and knowledgeable decision to acquire the Consideration Shares. Such Shareholder has been furnished by Purchaser with copies of the Purchaser's filings listed in the attached Schedule and any documents which may have been available upon request, and such Vendor has carefully read such reports and any documents which were otherwise provided and understands and has evaluated the risks of making an investment in the Purchaser's Shares. Such Vendor has been afforded access to information concerning Purchaser and to its executive officers and has been afforded the opportunity to ask questions of, and receive answers from, Purchaser. Such Vendor has been given the opportunity to obtain such additional information in order for such Vendor to evaluate the merits and risks of the receipt of the Consideration Shares. Based upon such information received, such Vendor believes such Vendor has received full and adequate information concerning Purchaser and its proposed plan of operations.

(b) Such Vendor is generally familiar with the semiconductor industry since such Vendor has either been employed in such industry or has invested in business entities engaged in such industry.

(c) Such Vendor is taking the Consideration Shares for investment for such Vendor's own account only and not with a view to, or for resale in connection with, any unregistered "distribution" thereof within the meaning of the Securities Act of 1933, as amended (the "Act").

(d) Vendor understands that no United States federal or state agency has passed on, or made any recommendation or endorsement of, the Consideration Shares.

(e) Vendor understands that the Consideration Shares are being offered and sold to it in reliance on specific exemptions from or non-application of the registration requirements of federal and state securities laws and that Purchaser is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgements and understandings of Vendor set forth herein in order to determine the applicability of such exemptions and the suitability of Vendor to acquire the Consideration Shares.

(f) Purchaser is not a U.S. Person (as defined in Regulation S promulgated under the Act) and is not and will not be an affiliate (as defined in the Securities Exchange Act of 1934, as amended) of Purchaser. To enable Purchaser to avoid any withholding requirements under U.S. law, Vendor certifies under penalty of perjury that he, she or it is neither a citizen nor a resident of the United States and that his, her or its address set forth in the Purchase Agreement is correct.

(g) No public offer or solicitation of the Consideration Shares was made to Vendor and no offer of the Purchaser's Shares was made to Vendor while Vendor was present in the United States.

(h) At the time any buy order for the Consideration Shares was originated, Vendor was located outside the United States and is outside the United States on the date of the execution and delivery of this agreement and will be outside the United States on the Completion Date.

(i) Vendor is aware that the Consideration Shares have not been registered under the Act and may only be offered or sold pursuant to registration under the Act or an available exemption therefrom and the Vendor has not, and will not, engage in any public offering or distribution of the Consideration Shares or engage in any hedging transaction with respect thereto, except in accordance with the registration or exemptive provisions of the Act.

(j) Except to the extent the Consideration Shares have been registered under the Act, Vendor (i) will not, during the period commencing on the Completion Date and ending one year after the Completion Date (the "Distribution Compliance Period), offer or sell or agree to sell the Consideration Shares in the United States, to a U.S. Person or for the account or benefit of a U.S. Person other than in accordance with Rule 903 or 904, as applicable, of Regulation S and (ii) will, after the expiration of the Distribution Compliance Period, offer, sell, pledge or otherwise transfer the Consideration Shares only pursuant to registration under the Act or an available exemption therefrom and, in any case, in accordance with applicable United States federal and state securities laws.

(k) Vendor has been advised of, and is familiar with, has complied, and will comply, with the offering restrictions, and any other requirements, of Regulation S.

(l) The transactions contemplated by this Agreement (i) have not been pre-arranged by Vendor with a Purchaser located in the United States which is a U.S. Person, and (ii) are not part of a plan or scheme by Vendor to evade the registration provisions of the Act.

(m) Neither Vendor nor any of his, her or its affiliates has entered, has the intention of entering, or will during the Distribution Compliance Period enter into, with any U.S. Person, any put option, short position or other similar instrument or position with respect to the Purchaser's Shares or participate in any other attempt designed to hedge Vendors' risk with respect to the Consideration Shares in any manner which does not comply with the Act.

(n) Such Vendor (individually or together with such Vendor's investor representative who is not affiliated with Purchaser) has such knowledge and experience in financial, tax and business matters that such Vendor is capable of evaluating the merits and risks of receiving the Consideration Shares and of making an informed investment decision with respect thereto.

(o) Such Vendor has determined that the Consideration Shares are a suitable investment.

(p) If such Vendor will be a director, officer or employee of the Purchaser or the Company following the Completion Date or have other confidentiality obligations to Purchaser, such Vendor acknowledges receipt of Purchaser's Insider Trading Policy and agrees to abide by its terms, and further agrees to execute such Policy upon the request of Purchaser.

(q) The certificates representing the Consideration Shares shall bear the following legend:

"The securities represented hereby have been issued pursuant to Regulation S ("Regulation S") promulgated under the Securities Act of 1933, as amended (the "1933 Act"), and have not been registered under the 1933 Act. Unless so registered, such securities may not be transferred, offered, hedged or sold prior to the end of the one-year distribution compliance period prescribed by Regulation S unless such transfer, offer, hedge or sale is made in an "offshore transaction" and not to or for the account of or benefit of a "U.S. Person" (as such terms are defined in Regulation S) and is otherwise in accordance with the requirements of Regulation S. Following expiration of any such one-year distribution compliance period, the securities represented hereby may not be offered, sold or otherwise transferred in the United States or to a U.S. Person unless the securities are registered under the 1933 Act and applicable state securities laws, or such offers, sales and transfers are made pursuant to an available exemption from the registration requirements of those laws."

(r) Vendor shall indemnify Purchaser against any loss, cost or damages (including reasonable attorneys' fees and expenses) incurred as a result of Vendor's breach of any representation, warranty, covenant or agreement in this Agreement.

SECTION 9. MISCELLANEOUS.

(a) Amendments, Waivers and Consents. No amendment or modification of this Agreement, nor any termination or waiver of any provision of this Agreement or consent to any departure by any party hereto therefrom, shall in any event be effective without the written concurrence of the parties hereto.

(b) Notices. Notices and other communications under or in connection with this Agreement shall be in writing and shall be deemed given (i) if delivered personally, upon delivery, (ii) if delivered by courier, then upon receipt, or (iii) if given by telecopy, upon confirmation of transmission by telecopy (or, if such confirmation does not occur during normal business hours on a Business Day (as defined in the Purchase Agreement), then on the next Business Day), in each case to the parties at the address for notice set forth on Schedule 1 to the Purchase Agreement.

(c) Applicable Law. This Agreement shall be construed, interpreted and the rights of the parties determined in accordance with English law and the United States federal securities laws without reference to any choice of law rules that would require the application of the laws of any other jurisdiction.

(d) Severability. The provisions of this Agreement are severable, and if any Section or provision shall be held invalid or unenforceable in whole or in part in any jurisdiction, then such invalidity or unenforceability shall affect only such Section or provision, or part thereof, in such jurisdiction and shall not in any manner affect such Section or provision in any other jurisdiction, or any other Section or provision of this Agreement in any jurisdiction.

(e) Interpretation. Time is of the essence of each provision of this Agreement of which time is an element.

(f) Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of each of the parties hereto and their respective successors, heirs and assigns.

(g) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which shall together constitute one and the same agreement.

(h) Purchaser's Representation. Purchaser represents and warrants to Vendors that, since the end of its most recent third fiscal quarter, there has been no material adverse change in the business, assets, financial condition or results of operations of Purchaser.

[SIGNATURES APPEAR ON FOLLOWING PAGES]

For and on behalf of the Vendors

By

as Attorney

Signature:

REPRESENTATIVE:

by his attorney

Signature:

FUTURELINK CORP.

By:

An Authorised Representative

Enter text✕

What a Letter Appointment Form Is and When It’s Used

A Letter Appointment Form is a written document that designates an individual or firm to act on behalf of another party for a specific task, engagement, or legal matter. Commonly used in legal, financial, real estate, and healthcare contexts, the form records the appointee’s scope of authority, effective date, duration, and any limitations. It creates a clear record of delegation and acceptance, helps third parties verify who may act, and can be combined with supporting identification or corporate resolutions. Proper completion supports enforceability under state law and federal e-signature statutes.

Why Documenting an Appointment Matters

Use a Letter Appointment Form to establish authority, reduce disputes, and create an auditable record of delegation. When signed electronically in the U.S., the form is enforceable under ESIGN and UETA provided intent, consent, attribution, and retention requirements are met.

Why Documenting an Appointment Matters

Who Commonly Prepares and Signs These Forms

Individuals, companies, and practitioners use Letter Appointment Forms to document delegated authority for transactions, claims, or administrative tasks.

  • Legal and compliance teams: prepare appointment letters for representation and corporate actions.
  • Real estate agents and property managers: designate leasing or sales representatives.
  • Healthcare administrators and practice managers: appoint authorized staff for records or billing tasks.

The form is suitable for anyone who needs to show clear, signed authority to act and for third parties that must verify that authority.

Core Sections to Include in a Professional Letter Appointment Form

Essential sections ensure clarity, limit scope, document acceptance, and state duration and conditions to reduce disputes and support enforceability by third parties.

Appointment

Identify appointing party and appointee by full legal name, business name if applicable, and contact details to ensure identification and correspondence routing. Include tax ID or professional license numbers where relevant.

Authority

Describe permitted actions in specific language — sign documents, appear before agencies, execute agreements — avoid vague phrases and list any excluded powers explicitly.

Duration

State effective date using MM/DD/YYYY format, specify end date or triggering event, and note whether renewal is automatic or requires separate approval; include time zone for deadlines.

Limitations

List geographic, monetary, or subject-matter limits. Include caps on spending, limits on contract size, or excluded transaction types and identify reporting requirements for high-value actions.

Acceptance

Have the appointee sign, print name, date, and provide contact and identification details; include a clause acknowledging acceptance of responsibilities and whether the agent may delegate further.

Notices

Specify how official notices are delivered (mail, email, courier), required delivery addresses or inboxes, and when notice is deemed received; include return-receipt or read-receipt requirements if needed.

Step-by-Step: From Draft to Final Record

A concise sequence for completing and executing a Letter Appointment Form, from drafting to final retention.

  • 01
    Draft form: Insert parties, scope, and effective dates.
  • 02
    Add supporting IDs: Attach ID copies or license numbers.
  • 03
    Sign and witness: Obtain signatures; notarize or witness if required.
  • 04
    Distribute and retain: Send copies to stakeholders and store securely.

Typical Online Workflow Settings for Electronic Completion

Configure an online Letter Appointment workflow to collect signatures, attach evidence, and automate notifications and reminders.

Field Configuration
Signature method Email link with optional SMS code or KBA for higher assurance
Authentication Choose email-only, SMS OTP, or ID verification for RON
Attachments Require ID, licenses, or exhibits at signing
Notifications Automatic emails for signer actions and completion

How the Form Is Routed and Stored

Routing steps that show who receives the form, how it is authenticated, and where final copies are stored.

  • Prepare: Populate fields and attach IDs.
  • Send: Distribute via secure email or signing link.
  • Authenticate: Use SMS, KBA, or RON where required.
  • Archive: Store signed PDF with audit trail.

Platform and Integration Considerations for eSigning

Ensure your platform supports required document formats, signer authentication levels, audit trails, and integrations with record systems to meet compliance and workflow needs.

  • Formats: PDF, DOCX; PDF/A for archival
  • Integrations: Salesforce, NetSuite, Google Workspace, Box
  • Authentication: Email link, SMS OTP, KBA, RON support

eSignature Pricing and Feature Comparison

Compare starting price, available trials, bulk-send capability, audit trails, HIPAA support, and envelope limits when choosing an eSignature vendor for Letter Appointment Form workflows.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No
Envelope Cap No cap 100 envelopes/user/year Varies Varies Varies

Common Preparation Mistakes to Avoid

  • Using vague authority language such as 'all matters' without limits, which can create unintended authority and disputes.
  • Failing to verify appointee identity or license, increasing risk of unauthorized acts and potential liability.
  • Omitting clear dates, renewal terms, or triggering events leads to ambiguity about when the appointment is active or terminated.
  • Not recording delivery or acceptance details (timestamps, email, IP) when e-signed reduces evidentiary strength in disputes.

Potential Consequences of an Incorrect or Incomplete Form

Document Invalidity: Vague terms may render appointment unenforceable.
Unauthorized Acts: Third-party reliance can create liability.
Tax Exposure: Incorrect TINs may trigger backup withholding.
Notarization Failure: Missing notarization leads to acceptance delays.
HIPAA Risk: Improper delegations can breach 45 CFR rules.
I-9 / Employment: Misfiled authorizations can trigger fines.

Essential Data Elements to Include

Appointing Party: Full legal name and entity type.
Appointee: Full legal name and contact details.
Scope: Clear list of permitted actions.
Effective Date: MM/DD/YYYY format required.
Signature Details: Signed name, title, date, and email.
Identification: ID numbers or license copies attached.

Practical Tips for More Accurate and Efficient Completion

Practical tips to improve clarity, reduce legal risk, and streamline execution when using a Letter Appointment Form.

Draft with precise scope
Use specific verbs and enumerated tasks. Define what the appointee may and may not do, include monetary or geographic caps, and state any prior approvals required. Precise drafting minimizes litigation risk and aids third-party verification.
Verify identity and authority
Attach government ID scans, professional licenses, or corporate resolutions as evidence. For corporate appointments, include a board resolution or corporate authorization. These attachments help third parties confirm authority and reduce fraud or unauthorized reliance.
Choose proper authentication
Match authentication level to transaction risk: use email for low-risk, SMS OTP or KBA for moderate risk, and RON or in-person notarization for high-value or legally sensitive appointments. Document the chosen method for evidentiary clarity.
Keep auditable records
Preserve signed PDFs with complete audit trails showing timestamps, IP addresses, signer email, and authentication steps. Store copies in secure systems with access controls and retention settings aligned with compliance obligations.

How Organizations Use Letter Appointment Forms in Practice

Real-world examples show how Letter Appointment Forms resolve delegation, speed processes, and support compliance across industries.

Real Estate Closing

A property manager appointed an agent to sign lease amendments for multiple units, requiring clear limits on rent adjustments and contract size to prevent overspending.

  • Agent authorized to sign amendments under $5,000.
  • The appointment included dated scope, capped authority, and required reporting; electronic signatures with audit trails and attached ID expedited approvals and allowed the property manager to demonstrate delegated authority to third-party vendors and banks.

Healthcare Authorization

A clinic appointed a billing agent to submit claims and manage payments, requiring HIPAA-compliant addenda and strict access controls on patient records.

  • Agent allowed claim filing and payment reconciliation only.
  • The Letter Appointment Form specified data handling obligations under HIPAA (45 CFR §164.502), required a Business Associate Agreement, and used electronic signatures with timestamped audit trails to demonstrate consent and authorized access during audits.

Frequently Asked Questions About Letter Appointment Forms

Answers to frequent questions about completing, signing, and enforcing a Letter Appointment Form, including e-signatures, notarization, and recordkeeping.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users